Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of <sup>68</sup>Ga-PSMA and <sup>68</sup>Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients.

Diagnostics (Basel) · 2021 · PMC8622332 · PMID 34829417

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

approached the level of significancep = 0.053so close (0.05 < p ≤ 0.1)

Tumour volume manually segmented on MR images presented a moderate association with GS that approached the level of significance (rho = 0.419, p = 0.053), while 68 Ga-PSMA PET and 68 Ga-DOTA-RM2 semi-quantitative parameters did not correlate with any of the considered clinical data ( p -value ≥ 0.05). 4.

also in 48 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.